Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1 Cvs Dr WOONSOCKET RI 02895-6146 |
Tel: | 1-800-2010938 |
Website: | https://cvshealth.com |
IR: | See website |
Key People | ||
Karen S. Lynch President, Chief Executive Officer, Director | Brian A. Kane Executive Vice President and President of Aetna | Thomas F. Cowhey Chief Financial Officer, Executive Vice President |
Laurie P. Havanec Chief People Officer, Executive Vice President | Tilak Mandadi Executive Vice President, Chief Data, Digital and Technology Officer | Sam S. Khichi Executive Vice President, Chief Policy Officer and General Counsel |
Thomas M. Moriarty Executive Vice President, General Counsel, Chief Policy and External Affairs Officer | Amy Bricker Executive Vice President, Chief Product Officer - Consumer | Sreekanth K. Chaguturu Executive Vice President, Chief Medical Officer | J. David Joyner Executive Vice President, President - Pharmacy Services |
Business Overview |
CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration. |
Financial Overview |
For the fiscal year ended 31 December 2023, CVS Health Corp revenues increased 11% to $357.78B. Net income increased 94% to $8.34B. Revenues reflect Health Services segment increase of 10% to $186.84B, Health Care Benefits segment increase of 16% to $105.65B, Comp. Store Sales (Growth - %) - Pharmay increase of 43% to 13.6%, Retail Sales-Retail Pharmacy increase of 12% to $92.11B. |
Employees: | 300,000 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $150,529M as of Dec 31, 2023 |
Annual revenue (TTM): | $357,776M as of Dec 31, 2023 |
EBITDA (TTM): | $19,498M as of Dec 31, 2023 |
Net annual income (TTM): | $8,344M as of Dec 31, 2023 |
Free cash flow (TTM): | $7,263M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $50,155M as of Dec 31, 2023 |
Shares outstanding: | 1,258,449,553 as of Jan 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |